- $230.57m
- $202.04m
- $529.74m
Annual income statement for Canaan, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 6-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 773 | 652 | 211 | 269 | 530 |
| Cost of Revenue | |||||
| Gross Profit | 442 | 230 | -241 | -84.3 | 41.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 490 | 609 | 622 | 496 | 642 |
| Operating Profit | 283 | 42.9 | -411 | -227 | -112 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 317 | 88.3 | -465 | -172 | -207 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 309 | 69.9 | -414 | -250 | -210 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 309 | 69.9 | -414 | -250 | -210 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 309 | 69.9 | -414 | -250 | -210 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.12 | 0.03 | -0.154 | -0.061 | -0.029 |